Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Transcriptomic Analysis to Put an End to Misdiagnosis in Patients With Rare Muscle Diseases

NCT06833489 is registered in ClinicalTrials.gov with Assistance Publique Hopitaux De Marseille as lead sponsor.

NCT NCT06833489
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06833489 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Transcriptomic Analysis to Put an End to Misdiagnosis in Patients With Rare Muscle Diseases
Lead sponsor
Assistance Publique Hopitaux De Marseille
Phase
Not applicable
Overall status
Recruiting
Start date
March 1, 2025
Completion date
March 1, 2027
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

congenital myopathy, muscular dystrophy, becker, muscular dystrophy, duchenne, pompe disease (infantile-onset), rare genetic muscle diseases